Lilly Reports Second-Quarter Financial Results, Raises EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St indexes eye weekly losses; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
Eli Lilly & Co. (LLY) Tops Q2 EPS by 33c, Raises FY EPS Guidance
July 30, 2020 6:27 AM EDTEli Lilly & Co. (NYSE: LLY) reported Q2 EPS of $1.89, $0.33 better than the analyst estimate of $1.56. Revenue for the quarter came in at $5.5 billion versus the consensus estimate of $5.76 billion.
GUIDANCE:
Eli Lilly & Co. sees FY2020 EPS of $7.20-$7.40, versus... More
